These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 26133247)

  • 21. VITRECTOMY FOR PERSISTENT MACULAR HOLES FOLLOWING OCRIPLASMIN INJECTION: A Comparative Multicenter Study.
    Schumann RG; Wolf A; Hoerauf H; Lommatzsch A; Maier M; Wachtlin J; Koss MJ; Kreutzer T; Bertelmann T; Kazerounian S; Mennel S; Priglinger SG
    Retina; 2017 Dec; 37(12):2295-2303. PubMed ID: 28098729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ocriplasmin on the management of macular holes: assessment of the clinical relevance of ocriplasmin.
    Moisseiev J; Moroz I; Katz G
    JAMA Ophthalmol; 2014 Jun; 132(6):709-13. PubMed ID: 24723009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological Reconstitution and Persistent Changes After Intravitreal Ocriplasmin for Vitreomacular Traction and Macular Hole.
    Zandi S; Freiberg F; Vaclavik V; Pfister IB; Traine PG; Kaya C; Michels S; Garweg JG
    J Ocul Pharmacol Ther; 2020 Mar; 36(2):126-132. PubMed ID: 31934816
    [No Abstract]   [Full Text] [Related]  

  • 24. IMPACT OF VITREORETINAL INTERFACE ARCHITECTURE ON SUCCESSFUL VITREOMACULAR TRACTION RESOLUTION IN EYES SCHEDULED FOR INTRAVITREAL OCRIPLASMIN THERAPY.
    Paul C; Heun C; Müller HH; Fauser S; Kaymak H; Kazerounian S; Sekundo W; Mennel S; Meyer CH; Schmitz-Valckenberg S; Koss MJ; Feltgen N; Bertelmann T
    Retina; 2017 Jul; 37(7):1252-1260. PubMed ID: 27787446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrastructure of the vitreomacular interface in full-thickness idiopathic macular holes: a consecutive analysis of 100 cases.
    Schumann RG; Schaumberger MM; Rohleder M; Haritoglou C; Kampik A; Gandorfer A
    Am J Ophthalmol; 2006 Jun; 141(6):1112-1119. PubMed ID: 16765681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study.
    Chatziralli I; Theodossiadis G; Parikakis E; Datseris I; Theodossiadis P
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):223-33. PubMed ID: 25940555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction.
    Gandorfer A; Rohleder M; Grosselfinger S; Haritoglou C; Ulbig M; Kampik A
    Am J Ophthalmol; 2005 Apr; 139(4):638-52. PubMed ID: 15808159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed full-thickness macular hole closure without vitreomacular traction release following ocriplasmin injection.
    Abou Ltaif S; Herbert L
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26359463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EXPERIENCE WITH OCRIPLASMIN IN PATIENTS WITH VITREOMACULAR TRACTION SYNDROME: A RETROSPECTIVE STUDY OF 10 PATIENTS.
    Bormann C; Apitzsch BC; Habermann A; Hammer U; Hammer T
    Retin Cases Brief Rep; 2020; 14(4):377-380. PubMed ID: 29621042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment outcomes and spectral-domain optical coherence tomography findings of eyes with symptomatic vitreomacular adhesion treated with intravitreal ocriplasmin.
    Warrow DJ; Lai MM; Patel A; Raevis J; Berinstein DM
    Am J Ophthalmol; 2015 Jan; 159(1):20-30.e1. PubMed ID: 25220823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of intravitreal ocriplasmin treatment for vitreomacular traction in clinical practice.
    Schumann RG; Langer J; Compera D; Luedtke K; Schaumberger MM; Kreutzer T; Mayer WJ; Wolf A; Priglinger SG
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2081-2089. PubMed ID: 28755165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitrectomy for Diabetic Macular Edema: Optical Coherence Tomography Criteria and Pathology of the Vitreomacular Interface.
    Hagenau F; Vogt D; Ziada J; Guenther SR; Haritoglou C; Wolf A; Priglinger SG; Schumann RG
    Am J Ophthalmol; 2019 Apr; 200():34-46. PubMed ID: 30557531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral vitreomacular traction resolved with a single intravitreal ocriplasmin injection.
    Katz RS
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(3):239-42. PubMed ID: 24708167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cells at the vitreoretinal interface in small full-thickness macular holes.
    Schumann RG; Hagenau F; Haritoglou C; Wolf A; Schaumberger MM; Kampik A; Gandorfer A
    Retina; 2015 Jun; 35(6):1158-65. PubMed ID: 25621947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction.
    Kaiser PK; Kampik A; Kuppermann BD; Girach A; Rizzo S; Sergott RC
    Retina; 2015 Jun; 35(6):1111-27. PubMed ID: 25635577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline Predictors of Vitreomacular Adhesion/Traction Resolution Following an Intravitreal Injection of Ocriplasmin.
    Jackson TL; Regillo CD; Girach A; Dugel PU;
    Ophthalmic Surg Lasers Imaging Retina; 2016 Aug; 47(8):716-23. PubMed ID: 27548448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocriplasmin versus vitrectomy for the treatment of macular holes.
    Juncal VR; Chow DR; Vilà N; Kapusta MA; Williams RG; Kherani A; Berger AR
    Can J Ophthalmol; 2018 Oct; 53(5):441-446. PubMed ID: 30340707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal ocriplasmin: A breakthrough in the treatment of vitreomacular traction?
    Mec-Słomska AE; Adamiec-Mroczek J; Kuźmicz E; Misiuk-Hojło M
    Adv Clin Exp Med; 2017; 26(3):527-531. PubMed ID: 28791829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study.
    Greven MA; Garg S; Chiu B; Shah SP; Wolfe J; Fine HF; Roth DB; Robinson J; Mong J; Hsu J; Regillo C; Ho A; Haller JA
    Br J Ophthalmol; 2016 Sep; 100(9):1211-5. PubMed ID: 26659344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of autologous plasmin for idiopathic macular hole surgery.
    Sakuma T; Tanaka M; Inoue M; Mizota A; Souri M; Ichinose A
    Eur J Ophthalmol; 2005; 15(6):787-94. PubMed ID: 16329067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.